Seger Surgical Solutions Business
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Core Technology
—
Tags (6)
medical-technologiesmedical-devicessurgerylaparoscopysurgeonsgastroenterology
Seger Surgical Solutions Financials
Undisclosed
Capital raised
Cumulative Funding Raised Over Time ($)
Private Equity Funding
The Trendlines Group, Israel Innovation Authority
Seger Surgical Solutions Lifecycle
Cumulative Funding Raised Over Time
All Events
The Trendlines Group, Israel Innovation Authority
Seger Surgical Solutions News
1 article
Seger Develops Next Gen Laparoscopic Bowel Closure Device
Seger Surgical Solutions has announced the development of its next generation laparoscopic stapler for intracorporeal anastomosis. The device aims to provide simple and rapid closure for common enterotomy. Seger has completed animal studies and is collaborating with Waston Medical, a Chinese medical device company, for human trials and FDA clearance. The laparoscopic stapler aims to improve clinical results, reduce complications, and lower healthcare costs. Millennium Research Group projects over 1.2 million bowel resections in the United States and E.U. in 2022, with annual growth of 10%. Seger Surgical Solutions was founded in 2016 and has received funding from The Trendlines Group and The Israel Innovation Authority.
PartnersInvestment
Seger Surgical Solutions Team
Leo R. Mindick
Co-founder & Investor
Founder
Prof. Barry Salky
Co-founder & Medical Director
Founder
David Hazzan
Clinical Director
Employee Info
| Employees (range) | 1-10 |
| Exact count | 4 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 6 classification IDs that could be used for matching.